Universidad San Sebastián
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
González, Pablo
NCT05431725: Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Completed
3
2202
RoW
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, Sinovac-QIV, Control Quadrivalent influenza virus vaccine, Vaxigrip Tetra-QIV
Sinovac Biotech Co., Ltd, Pontificia Universidad Catolica de Chile, Sinovac Biotech Co., Ltd
Seasonal Influenza
07/23
07/23
TAK-279-PsO-3003, NCT06550076: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting
3
1300
Europe, Canada, Japan, US, RoW
TAK-279
Takeda
Plaque Psoriasis
05/26
05/26
TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Active, not recruiting
3
1108
Europe, Canada, US, RoW
TAK-279, Placebo, Apremilast
Takeda
Plaque Psoriasis
12/24
11/25
CoronaVarCL, NCT05593042: Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile

Completed
2
551
RoW
CoronaVac®, Inactivated SARS-CoV-2 Vaccine (Vero Cells) - Sinovac, Omicron Vaccine, Trivalent Vaccine
Pontificia Universidad Catolica de Chile, Sinovac Life Sciences Co., Ltd.
COVID-19, Vaccines
10/23
10/23
Bueno, Susan M
CoronaVarCL, NCT05593042: Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile

Completed
2
551
RoW
CoronaVac®, Inactivated SARS-CoV-2 Vaccine (Vero Cells) - Sinovac, Omicron Vaccine, Trivalent Vaccine
Pontificia Universidad Catolica de Chile, Sinovac Life Sciences Co., Ltd.
COVID-19, Vaccines
10/23
10/23
Alves, Nilton
No trials found
Monardes, Hector
No trials found

Download Options